Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of V419 (Vaxelis) in Healthy Infants
NCT01480258Phase 3Completed
- Sponsor
- MCM Vaccine
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 3 trial of DTaP-IPV-Hep B-PRP-T vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by MCM Vaccine. Started Nov 2011; status: completed.
02
Drugs
DTaP-IPV-Hep B-PRP-T vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT01480258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480258.